Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Usefullnes of chest computed tomography as a tool to predict COPD exacerbations

João Nunes Caldeira Marinho Matos, Sofia Rodrigues Sousa, Lídia Sousa Gomes, Cidália Rodrigues
European Respiratory Journal 2021 58: PA3834; DOI: 10.1183/13993003.congress-2021.PA3834
João Nunes Caldeira Marinho Matos
1Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: joaoncaldeira@gmail.com
Sofia Rodrigues Sousa
1Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lídia Sousa Gomes
1Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cidália Rodrigues
1Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction: Phenotyping of COPD patients by chest computed tomography (CT) has been shown to correlate with pulmonary function parameters. Whether if it is of interest in prediction of COPD exacerbations is under investigation.

Objectives: To evaluate the association of COPD CT phenotyping with patients’ exacerbations profiles.

Methods: Retrospective analysis of COPD patients’ exacerbation history during a 1-year period. Patients were classified into normal, air dominant, emphysema dominant and mixed type based on CT scans using two cutoffs: percentage of low attenuation area (%LAA) less than a threshold of -950 Hounsfield units of 15% and the upper quartile value of the percentage of bronchial wall area (WA%/BSA). Exacerbation and its severity were defined accordingly to the GOLD 2021 report.

Results: A total of 80 patients were evaluated. Median age was 66.5 (IQR 16) years. Mean number of exacerbations was 1 (±1.2) for the normal phenotype; 0.74 (±1.5) for air-dominant; 1.9 (±2.6) for emphysema-dominant; and 1 (±1.4) for mixed-type. There were no statistical differences regarding having an exacerbation, the number of exacerbations, nor the severity of the exacerbation (respectively, p=0.937; p=0.315; and severe: p=0.579; mild: p=0.388; and light: p=0.620). COPD CT phenotyping did not statistically predict the occurrence of exacerbations of any severity (X2=0.417, p=0.937, R2=0.007), neither the number of exacerbations (F[1,78]=0.255,p=0.615, R2=0.003). Similar results were found when analyzing each level of severity individually.

Conclusions: In our sample, COPD CT phenotyping did not statistically predict COPD exacerbations. Our results lead us to recommend against its use for this purpose.

  • COPD - management
  • COPD - exacerbations
  • Exacerbation

Footnotes

Cite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA3834.

This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2021
Previous
Back to top
Vol 58 Issue suppl 65 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Usefullnes of chest computed tomography as a tool to predict COPD exacerbations
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Usefullnes of chest computed tomography as a tool to predict COPD exacerbations
João Nunes Caldeira Marinho Matos, Sofia Rodrigues Sousa, Lídia Sousa Gomes, Cidália Rodrigues
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3834; DOI: 10.1183/13993003.congress-2021.PA3834

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Usefullnes of chest computed tomography as a tool to predict COPD exacerbations
João Nunes Caldeira Marinho Matos, Sofia Rodrigues Sousa, Lídia Sousa Gomes, Cidália Rodrigues
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3834; DOI: 10.1183/13993003.congress-2021.PA3834
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Late Breaking Abstract - The SF-36 quality of life scales are sensitive measures of lung function decline
  • Late Breaking Abstract - Adrenal function improvement after oral corticosteroid reduction in benralizumab-treated severe eosinophilic asthma: PONENTE maintenance phase
Show more Monitoring airway disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society